MedAmicus to sell Schick densitometer

Article

Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it

Medical technology firm MedAmicus has signed an agreement with Schick Technologies to distribute that firm's accuDEXA bone densitometer (SCAN 4/15/98). MedAmicus, of Plymouth, MN, will add accuDEXA to its line of diagnostic testing products it sells to physicians' offices. The company will price the densitometer at under $13,000, with shipments expected to begin by the end of April.

In other Schick news, the Long Island City, NY, company reported on April 14 that it expects revenues for its fourth quarter (end-March) to be between $12 million and $13 million. The figures are much higher than the $5.4 million in sales Schick recorded in the same period last year, but are short of expectations due to the late delivery of components from a supplier, which prevented Schick from fulfilling orders worth between $2 million and $3 million. The delays have been resolved, and the products should ship in its first fiscal quarter, according to Schick.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.